Meta-analysis of 6 randomised trials (5,924 patients) with chronic coronary syndrome needing long-term anticoagulation: OAC alone vs OAC plus single antiplatelet showed similar MACE (6.8% vs 8.2%; HR 0.85, 95% CI 0.64–1.09) and less bleeding (8.9% vs 16.1%; HR 0.49).
Meta-analysisn = 5,924
Galli et al. Oral Anticoagulation With or Without Antiplatelet Therapy in Chronic Coronary Syndrome: A Meta-Analysis of Randomized Trials